Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Waarts MR"'
Autor:
Bowman RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: robert.bowman@pennmedicine.upenn.edu., Dunbar AJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mishra T; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Xiao W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Waarts MR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Maestre IF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Eisman SE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cai L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mowla S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shah N; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Youn A; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Bennett L; Department of Cell and Developmental Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Fontenard S; Department of Cell and Developmental Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Gounder S; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Gandhi A; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Bowman M; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., O'Connor K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Zaroogian Z; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sánchez-Vela P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Martinez Benitez AR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Werewski M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Park Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Csete IS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Krishnan A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lee D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Boorady N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Potts CR; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37212 USA., Jenkins MT; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37212 USA., Cai SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Carroll MP; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Meyer SE; Department of Cancer Biology, Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, PA 19107, USA., Miles LA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ferrell PB Jr; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37212 USA., Trowbridge JJ; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: leviner@mskcc.org.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Nov 11; Vol. 42 (11), pp. 1955-1969.e7.
Autor:
Waarts MR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Mowla S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Boileau M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Martinez Benitez AR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Sango J; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Center for Advancement of Blood Cancer Therapies, Institute for Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Bagish M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Fernández-Maestre I; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Shan Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Eisman SE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Park YC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wereski M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Csete I; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., O'Connor K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Romero-Vega AC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Miles LA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio., Xiao W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Wu X; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Shih AH; Division of Hematology Oncology, Department of Medicine, Tisch Cancer Institute (TCI), Icahn School of Medicine at Mount Sinai, New York, New York., Papapetrou EP; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Center for Advancement of Blood Cancer Therapies, Institute for Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Butler JM; Department of Medicine, University of Florida Health Cancer Center, Gainesville, Florida., Cai SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Bowman RL; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Oct 04; Vol. 14 (10), pp. 1860-1878.
Autor:
Dunbar AJ; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.; Myeloproliferative Neoplasm-Research Consortium., Bowman RL; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Park YC; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., O'Connor K; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Izzo F; Weill Cornell Medical College of Cornell University, New York, New York.; New York Genome Center, New York, New York., Myers RM; Weill Cornell Medical College of Cornell University, New York, New York.; New York Genome Center, New York, New York., Karzai A; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Zaroogian Z; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Kim WJ; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Fernández-Maestre I; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Waarts MR; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Nazir A; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Xiao W; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Codilupi T; Department of Biomedicine, University of Basel, Basel, Switzerland., Brodsky M; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland., Farina M; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, University of Brescia, ASST Spedali Civili di Brescia, Italy., Cai L; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Cai SF; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Wang B; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., An W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Yang JL; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Mowla S; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Eisman SE; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Hanasoge Somasundara AV; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Glass JL; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Mishra T; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Houston R; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Guzzardi E; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Martinez Benitez AR; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Viny AD; Division of Hematology and Oncology, Department of Medicine and Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, New York., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Meyer SC; Department of Biomedicine, University of Basel, Basel, Switzerland.; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Landau DA; Weill Cornell Medical College of Cornell University, New York, New York.; New York Genome Center, New York, New York., Levine RL; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.; Myeloproliferative Neoplasm-Research Consortium.; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 May 01; Vol. 14 (5), pp. 737-751.
Autor:
Waarts MR; Gerstner Sloan Kettering Graduate Program in Biomedical Sciences.; Human Oncology and Pathogenesis Program.; Center for Hematologic Malignancies.; Center for Epigenetics Research, and., Stonestrom AJ; Human Oncology and Pathogenesis Program.; Center for Hematologic Malignancies.; Center for Epigenetics Research, and.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Park YC; Human Oncology and Pathogenesis Program.; Center for Hematologic Malignancies.; Center for Epigenetics Research, and., Levine RL; Human Oncology and Pathogenesis Program.; Center for Hematologic Malignancies.; Center for Epigenetics Research, and.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2022 Apr 15; Vol. 132 (8).
Autor:
Xiao W; Department of Pathology, Hematopathology Service.; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Chan A; Department of Pathology, Hematopathology Service., Waarts MR; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Mishra T; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Liu Y; Department of Pathology, Hematopathology Service., Cai SF; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service.; Department of Medicine, Leukemia Service., Yao J; Department of Pathology, Molecular Diagnostic Laboratory., Gao Q; Department of Pathology, Hematopathology Service., Bowman RL; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Koche RP; Center for Epigenetics Research., Csete IS; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., DelGaudio NL; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service., Derkach A; Department of Epidemiology-Biostatistics., Baik J; Department of Pathology, Hematopathology Service., Yanis S; Department of Pathology, Hematopathology Service., Famulare CA; Center for Hematologic Malignancies, and., Patel M; Center for Hematologic Malignancies, and., Arcila ME; Department of Pathology, Hematopathology Service.; Department of Pathology, Molecular Diagnostic Laboratory., Stahl M; Department of Medicine, Leukemia Service., Rampal RK; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service.; Department of Medicine, Leukemia Service., Tallman MS; Department of Medicine, Leukemia Service., Zhang Y; Department of Pathology, Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Department of Pathology, Hematopathology Service., Goldberg AD; Department of Medicine, Leukemia Service., Roshal M; Department of Pathology, Hematopathology Service., Levine RL; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service.; Department of Medicine, Leukemia Service.; Center for Epigenetics Research.; Center for Hematologic Malignancies, and.
Publikováno v:
Blood [Blood] 2021 Mar 11; Vol. 137 (10), pp. 1377-1391.
Autor:
Baeten JT; University of Chicago, Biological Sciences Division, Department of Pediatrics, Chicago., Waarts MR; University of Chicago, Biological Sciences Division, Department of Pediatrics, Chicago., Pruitt MM; University of Chicago, Biological Sciences Division, Department of Pediatrics, Chicago., Chan WC; University of Chicago, Center for Research Informatics, Chicago, IL, USA., Andrade J; University of Chicago, Center for Research Informatics, Chicago, IL, USA., de Jong JLO; University of Chicago, Biological Sciences Division, Department of Pediatrics, Chicago jdejong@peds.bsd.uchicago.edu.
Publikováno v:
Haematologica [Haematologica] 2019 Jul; Vol. 104 (7), pp. 1388-1395. Date of Electronic Publication: 2019 Jan 10.
Autor:
Pruitt MM; Department of Pediatrics, Section of Hematology-Oncology, The University of Chicago; Department of Biology and Biotechnology, Worcester Polytechnic Institute., Marin W; Department of Pediatrics, Section of Hematology-Oncology, The University of Chicago., Waarts MR; Department of Pediatrics, Section of Hematology-Oncology, The University of Chicago., de Jong JLO; Department of Pediatrics, Section of Hematology-Oncology, The University of Chicago; jdejong@peds.bsd.uchicago.edu.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2017 May 04 (123). Date of Electronic Publication: 2017 May 04.